
Oncologist 🇱🇰 Editor-in-Chief RCR Open @RCRadiologists
Sri Lanka
Joined December 2008
- Tweets1.9K
- Following541
- Followers395
- Likes4.3K
Pinned Tweet
The protocol for our HYPOCON #trial for locally advanced #HNSCC is out in @ClinicalOnc Investigating an innovative biphasic #radiotherapy #fractionation schedule across #SriLanka. Brilliant collaboration with @remediumone @sueyom @achoud72 #RadOnc
authors.elsevier.com/a/1nqW6…
Nuradh Joseph retweeted
Replying to @MCRCnews
Treatment of the primary after exceptional response in metastatic #BladderCancer. @achoud72 @TheChristieNHS and Alexandra Masson-Lecomte, MD, MS @HopSaintLouis
join @shilpaonc @ClevelandClinic to discuss on UroToday. #WatchNow > bit.ly/4hY7FvW @IBCG_BladderCA #IBCG2026 #IBCG26 @UroDocAsh
Nuradh Joseph retweeted
For Christians, the poor are not a sociological category, but the very ‘flesh’ of Christ. Christ, poor and crucified, continues to allow Himself to be encountered and loved through these men and women, who call us to go beyond ourselves and to dare to practice charity. #ApostolicJourney #France vatican.va/content/leo-xiv/e…
It is the same globally and more so in #LMIC s. Pragmatic #clinicalresearch is not only under-funded #HealthPolicy makers but also under-valued by #clinicians themselves. #GlobalOncology #Oncology #Radonc @achoud72 @NicholasZaorsky
In American medicine, research is the price of admission but rarely a viable career. Trainees are told it's essential for competitive medical school and residency positions. As faculty, they confront scarce protected time, billing-driven productivity metrics, low grant-funding rates, long funding cycles, and salary-cap gaps their institutions are asked to absorb, just as family and financial obligations grow. Pragmatic clinical research is poorly supported, especially outside well-resourced centers. The incentives favor delivering costly care over improving it.
Nuradh Joseph retweeted
Although highly effective, many novel cancer therapeutics for early NSCLC prove to be prohibitively expensive. This comprehensive cost–utility analysis using an LMIC-appropriate willingness-to-pay threshold sought to identify economically viable options
bmjoncology.bmj.com/content/…,
Nuradh Joseph retweeted
"Our analyses show that in Sri Lanka’s state health system, four approved indications of novel cancer therapeutics for stage II-III NSCLC emerged as cost-effective at the primary willingness-to-pay threshold of US$6700 per QALY"
🔗 bmjoncology.bmj.com/content/…
This was a particularly great year for #ASCOBT26 with impressive representation from South Asia! This meeting is becoming a go-to in Asia and I'm happy to see its rapid development! @ASCO
Privileged to speak at #ASCOBreakthrough2026 on the intersection of #MolecularRadiotherapy and #Immunotherapy #ASCOBT26. Finally got to catchup with @achoud72 and meet @sueyom! @ASCO #radonc #oncology
Privileged to speak at #ASCOBreakthrough2026 on the intersection of #MolecularRadiotherapy and #Immunotherapy #ASCOBT26. Finally got to catchup with @achoud72 and meet @sueyom! @ASCO #radonc #oncology
New in @BMJOncology Our cost-utility analysis of novel rx for stage II-III #LungCancer in #SriLanka. Adjuvant osimertinib alectinib & neoadjuvant nivolumab cost-effective; others need major price cuts bmjoncology.bmj.com/content/… #oncology #HealthEconomics @SameeraSenanay3 @sanjee48
Nuradh Joseph retweeted
👏🏻Congratulations to Prof. Chandima Jeewandara on being appointed the first Director of the Institute of Allergology and Immunology.
🔬A landmark moment for our newly established institute at @usjp, advancing immunology, allergology, molecular medicine & biomedical engineering.
The Clinical Approach to Salvage Treatment of Locoregional #Tumour #Recurrence - co-authored with #whereishoskin published in @ClinOncology @MCRCnews @MVCCbrachy @RCRadiologists #radonc #cancer #oncology
sciencedirect.com/science/ar…
An early morning for #whereishoskin as he kicks off the @slconcology annual meeting with a breakfast session on #cancerresearch Lots of practical tips and wisdom from the legend himself.. Hope this translates into more #cancerresearch in #SriLanka @MCRCnews
@hiprabs #oncology
Healthcare & hashtags - a delicate balance An insightful keynote at the @slconcology annual meeting by the brilliant @sanjanah on #medical #disinformation on #socialmedia which spreads like cancer & metastatises in society leaving an incurable legacy of harm #srilanka @Gunti777
Nuradh Joseph retweeted
GLP-1 Receptor Agonists are powerful new💉 in assising weight loss, but do they cause cancer?
Just out in @JAMAOnc study in people from Florida with obesity
➡️Bottom line cancer incidence is lower overall in those taking GLP-1RA (HR=0.83 0.76-0.91)
🔗jamanetwork.com/journals/jam…
Our paper on Ensuring sustainable funding for novel #cancer #therapeutics through a budget impact analysis in #LMICs - published in #ecancer #SriLanka #healtheconomics #globaloncology #oncology @Vimukthini @prasaday @vodathi @nadajeyakumaran @Gunti777 ecancer.org/en/journal/artic…
Nuradh Joseph retweeted
THE conference where everyone brought their A-game! 1st ever APCCC South Asia 🇮🇳🇱🇰🇳🇵🇧🇩 edition😇 Fortunate to be a part of wonderfully exhaustive discussion s on everything in prostate cancer!
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx.
Plenty of friendly banter and leg pulling.
Official APCCC South Asia.
Paper with similarities yet differences from @APCCC_Lugano coming soon.
Thanks so much @VedangMurthy for putting together the first ever #APCCC #SouthAsia and for including #SriLanka. It was great to meet so many colleagues from #SouthAsia #Prostatecancer #oncology @Vimukthini @YasiruMalinda @docpriyamvada
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx.
Plenty of friendly banter and leg pulling.
Official APCCC South Asia.
Paper with similarities yet differences from @APCCC_Lugano coming soon.
Nuradh Joseph retweeted
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx.
Plenty of friendly banter and leg pulling.
Official APCCC South Asia.
Paper with similarities yet differences from @APCCC_Lugano coming soon.
#Repurposing Medications for #PalliativeCare - An insightful review authored by Sudhakaran, Das and Kondasinghe published in #RCROpen @RCRadiologists Useful practical tips for all #clinicians! #oncology #cancer @ClinOncology @OncologyAdvance
sciencedirect.com/science/ar…





























